Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised,...

por Saito, H., Yoshizawa, H., Yoshimori, K., Katakami, N., Katsumata, N., Kawahara, M., Eguchi, K.
Publicado 2013

Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.

por Segawa, Y., Kageyama, M., Suzuki, S., Jinno, K., Takigawa, N., Fujimoto, N., Hotta, K., Eguchi, K.
Publicado 1998

Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder.

por Tachibana, M., Miyakawa, A., Uchida, A., Murai, M., Eguchi, K., Nakamura, K., Kubo, A., Hata, J. I.
Publicado 1997

Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

por Saijo, N., Shimizu, E., Shibuya, M., Irimajiri, N., Takizawa, T., Eguchi, K., Shinkai, T., Tominaga, K., Shimabukuro, Z., Taniguchi, T., Hoshi, A.
Publicado 1982

Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)

por Komiyama, K, Kobayashi, K, Minezaki, S, Kotajima, F, Sutani, A, Kasai, T, Mori, K, Hoshi, E, Takayanagi, N, Koyama, S, Eguchi, K, Nakayama, M, Kikuchi, K
Publicado 2012

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the...

por Segawa, Y, Ueoka, H, Kiura, K, Kamei, H, Tabata, M, Sakae, K, Hiraki, Y, Kawahara, S, Eguchi, K, Hiraki, S, Harada for the Okayama Lung Cancer Study Group, Mine
Publicado 2000

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

por Ueoka, H, Tanimoto, M, Kiura, K, Tabata, M, Takigawa, N, Segawa, Y, Takata, I, Eguchi, K, Okimoto, N, Harita, S, Kamei, H, Shibayama, T, Watanabe, Y, Hiraki, S, Harada, M
Publicado 2001

Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.

por Ando, M., Eguchi, K., Shinkai, T., Tamura, T., Ohe, Y., Yamamoto, N., Kurata, T., Kasai, T., Ohmatsu, H., Kubota, K., Sekine, I., Hojo, N., Matsumoto, T., Kodama, T., Kakinuma, R., Nishiwaki, Y., Saijo, N.
Publicado 1997

Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507

por Sekine, I, Nishiwaki, Y, Kakinuma, R, Kubota, K, Hojo, F, Matsumoto, T, Ohmatsu, H, Goto, K, Kodama, T, Eguchi, K, Shinkai, T, Tamura, T, Ohe, Y, Kunitoh, H, Yoshimura, K, Saijo, N
Publicado 2003

Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

por Kiura, K, Ueoka, H, Segawa, Y, Tabata, M, Kamei, H, Takigawa, N, Hiraki, S, Watanabe, Y, Bessho, A, Eguchi, K, Okimoto, N, Harita, S, Takemoto, M, Hiraki, Y, Harada, M, Tanimoto, M
Publicado 2003

Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer

por Matsuyama, Masato, Ishii, H., Furuse, J., Ohkawa, S., Maguchi, H., Mizuno, N., Yamaguchi, T., Ioka, T., Ajiki, T., Ikeda, M., Hakamada, K., Yamamoto, M., Yamaue, H., Eguchi, K., Ichikawa, W., Miyazaki, M., Ohashi, Y., Sasaki, Y.
Publicado 2014

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer

por Ioka, T, Komatsu, Y, Mizuno, N, Tsuji, A, Ohkawa, S, Tanaka, M, Iguchi, H, Ishiguro, A, Kitano, M, Satoh, T, Yamaguchi, T, Takeda, K, Kida, M, Eguchi, K, Ito, T, Munakata, M, Itoi, T, Furuse, J, Hamada, C, Sakata, Y
Publicado 2017